HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia.

Abstract
Familial dysautonomia (FD), a hereditary sensory and autonomic neuropathy, is caused by missplicing of exon 20, resulting from an intronic mutation in the inhibitor of kappa light polypeptide gene enhancer in B cells, kinase complex-associated protein (IKBKAP) gene encoding IKK complex-associated protein (IKAP)/elongator protein 1 (ELP1). A newly established splicing reporter assay allowed us to visualize pathogenic splicing in cells and to screen small chemicals for the ability to correct the aberrant splicing of IKBKAP. Using this splicing reporter, we screened our chemical libraries and identified a compound, rectifier of aberrant splicing (RECTAS), that rectifies the aberrant IKBKAP splicing in cells from patients with FD. Here, we found that the levels of modified uridine at the wobble position in cytoplasmic tRNAs are reduced in cells from patients with FD and that treatment with RECTAS increases the expression of IKAP and recovers the tRNA modifications. These findings suggest that the missplicing of IKBKAP results in reduced tRNA modifications in patients with FD and that RECTAS is a promising therapeutic drug candidate for FD.
AuthorsMayumi Yoshida, Naoyuki Kataoka, Kenjyo Miyauchi, Kenji Ohe, Kei Iida, Suguru Yoshida, Takayuki Nojima, Yukiko Okuno, Hiroshi Onogi, Tomomi Usui, Akihide Takeuchi, Takamitsu Hosoya, Tsutomu Suzuki, Masatoshi Hagiwara
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 112 Issue 9 Pg. 2764-9 (Mar 03 2015) ISSN: 1091-6490 [Electronic] United States
PMID25675486 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carrier Proteins
  • Elp1 protein, human
  • Heterocyclic Compounds, 3-Ring
  • Transcriptional Elongation Factors
  • RNA, Transfer
Topics
  • Carrier Proteins (genetics, metabolism)
  • Dysautonomia, Familial (drug therapy, genetics, metabolism)
  • HeLa Cells
  • Heterocyclic Compounds, 3-Ring (chemistry, pharmacology)
  • Humans
  • Introns
  • Mutation
  • RNA Splicing (drug effects, genetics)
  • RNA, Transfer (genetics, metabolism)
  • Transcriptional Elongation Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: